Detalles de la búsqueda
1.
Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142.
Ann Oncol
; 33(10): 1052-1060, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35764271
2.
Distinct genomic landscapes of gastroesophageal adenocarcinoma depending on PD-L1 expression identify mutations in RAS-MAPK pathway and TP53 as potential predictors of immunotherapy efficacy.
Ann Oncol
; 32(7): 906-916, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33798656
3.
Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trials.
Ann Oncol
; 31(1): 88-95, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31912801
4.
Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial.
Ann Oncol
; 30(11): 1796-1803, 2019 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31868905
5.
Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1): a phase III, international, randomized, placebo-controlled study.
Ann Oncol
; 29(9): 1955-1963, 2018 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30010751
6.
Clinical relevance of EMT and stem-like gene expression in circulating tumor cells of metastatic colorectal cancer patients.
Pharmacogenomics J
; 18(1): 29-34, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27503579
7.
A genetic variant in Rassf1a predicts outcome in mCRC patients treated with cetuximab plus chemotherapy: results from FIRE-3 and JACCRO 05 and 06 trials.
Pharmacogenomics J
; 18(1): 43-48, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27698403
8.
Prognostic impact of FOXF1 polymorphisms in gastric cancer patients.
Pharmacogenomics J
; 18(2): 262-269, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28398355
9.
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials.
Ann Oncol
; 28(8): 1713-1729, 2017 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28407110
10.
Impact of genetic variations in the MAPK signaling pathway on outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI and bevacizumab: data from FIRE-3 and TRIBE trials.
Ann Oncol
; 28(11): 2780-2785, 2017 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29045529
11.
Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer.
Ann Oncol
; 28(5): 1015-1022, 2017 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28453695
12.
Germline polymorphisms as biomarkers of tumor response in colorectal cancer patients treated with anti-EGFR monoclonal antibodies: a systematic review and meta-analysis.
Pharmacogenomics J
; 17(6): 535-542, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27897268
13.
Estrogen receptor-beta genetic variations and overall survival in patients with locally advanced gastric cancer.
Pharmacogenomics J
; 17(1): 36-41, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26503819
14.
Genetic variations in immunomodulatory pathways to predict survival in patients with locoregional gastric cancer.
Pharmacogenomics J
; 17(6): 528-534, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27241062
15.
Genetic variants associated with colorectal brain metastases susceptibility and survival.
Pharmacogenomics J
; 17(1): 29-35, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26689941
16.
CXCR4 polymorphism predicts progression-free survival in metastatic colorectal cancer patients treated with first-line bevacizumab-based chemotherapy.
Pharmacogenomics J
; 17(6): 543-550, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27503580
17.
Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors.
Ann Oncol
; 27(2): 318-23, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26598548
18.
Germline polymorphisms in genes involved in the Hippo pathway as recurrence biomarkers in stages II/III colon cancer.
Pharmacogenomics J
; 16(4): 312-9, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-26370619
19.
Circulating cytokines and monocyte subpopulations as biomarkers of outcome and biological activity in sunitinib-treated patients with advanced neuroendocrine tumours.
Br J Cancer
; 112(7): 1199-205, 2015 Mar 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-25756398
20.
Reply to the letter to the editor 'Neutropenia in metastatic colorectal cancer receiving trifluridine/tipiracil' by Colloca et al.
Ann Oncol
; 31(8): 1085-1087, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32360742